Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

HQ
Belfield Innovation Park
Dublin, IRL

People

Funding

TOTAL $4.49M
FUNDING TOTAL $4.49M
Venture Round, 2/2008
Street Capital
Enterprise Ireland
Seroba Kernel
Atlantic Bridge
$2.93M
Venture Round, 12/2011
ACT Venture Capital
Atlantic Bridge
Seroba Kernel
€1.2M

Tags

Biosensia

Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing.

RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications.

Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.

Recent Milestones

Videos

Screenshots

Biosensia screenshot
Above: Biosensia Screenshot -- #1
Uploaded: 12/23/09

Sources

  1. EDGAR [edit]
  2. Biosensia Raises €1.2M in Funding (finsmes.com) [edit]
Edit This Page
Last Edited 6/7/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy